Archean Chemical Industries Limited — Important, 30-05-2026: Disclosure of material issue

Archean Chemical announces a strategic investment in its wholly-owned subsidiary, Acume Chemicals. Following board approval on May 11, 2026, the company plans to inject up to Rs. 170 Cr via a rights issue, subscribing to equity shares at face value.

This investment aims to significantly strengthen Acume's capital base, fund future business expansion, and support its operational needs. The move is expected to improve capacity utilization, optimize product mix, and reduce Acume's reliance on external borrowings.

Acume Chemicals, incorporated in November 2021 and focused on the Bromine Derivatives business, reported total assets of ~Rs. 286.50 Cr and revenue of ~Rs. 81.12 Cr as of March 31, 2026. Its turnover has shown strong growth, from Rs. 0.51 Cr in FY23 to Rs. 81.12 Cr in FY25. The investment is anticipated to be completed within one month from the rights offer. Archean will maintain its 100% shareholding in Acume post-issue.